Cancer Stem Cells as Promising Nanotherapeutic Targets

This chapter delves into the forefront of cancer therapeutics by examining the dynamic landscape of nanomedicine directed at cancer stem cells (CSCs). Beginning with a contextualization of cancer’s complexity and statistics, emphasis is placed on metastasis and the intricate tumor microenvironment as key drivers of therapeutic resistance and mortality. A focal point of the chapter is an in-depth exploration of CSCs, elucidating their definition, distinctive characteristics, and the underlying heterogeneity within their populations. Signalling pathways, including Notch, Wnt, Hedgehog, and Nanog regulation, are scrutinized for their roles in orchestrating CSC behavior. Transitioning to nanomedicine, the chapter unfolds the basics, applications, and advantages in cancer therapy. Various nanoparticles are scrutinized for their clinical use, while the discussion navigates through passive and active targeting strategies, drug delivery systems such as liposomes, polymeric nanoparticles, micelles, and carbon nanotubes. The integration of targeting ligands and surface modifications is explored alongside techniques for imaging and tracking nanomedicine delivery. Mechanistic insights unfold, detailing the interaction between nanomedicine and CSCs, the circumvention of drug resistance, induction of apoptosis, and modulation of the tumor microenvironment. The chapter meticulously dissects preclinical and clinical studies, delineating promising results, ongoing trials, and successful applications in diverse clinical settings. Safety considerations are paramount, delving into the biocompatibility of nanomaterials, potential toxicity, and strategic approaches to minimize adverse effects. Regulatory aspects and guidelines are navigated to ensure the ethical implementation of nanomedicine in cancer therapy. Looking forward, the chapter outlines emerging technologies, the integration of personalized medicine, and strategies to overcome resistance mechanisms. Ethical and societal implications underscore the holistic approach necessary for advancing cancer treatment.